Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (atsiveria naujas langas)

Barillari G, Pasca S, Barillari A, De Angelis V.

Šaltinis‎: Blood Transfus 2012;10(1):87-94.

Kodas‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (atsiveria naujas langas)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (atsiveria naujas langas)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Šaltinis‎: Chest 2012;141(2 Suppl):e326S-50S.

Kodas‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (atsiveria naujas langas)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (atsiveria naujas langas)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Šaltinis‎: Lancet 2015;385(9982):2077-87.

Kodas‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (atsiveria naujas langas)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (atsiveria naujas langas)

Hanke AA, Joch C, Görlinger K.

Šaltinis‎: Br J Anaesth 2013;110(5):764-72.

Kodas‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (atsiveria naujas langas)

Emergency reversal of warfarin anticoagulation. (atsiveria naujas langas)

Lin Y, Callum J.

Šaltinis‎: CMAJ 2010;182(18):2004.

Kodas‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (atsiveria naujas langas)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (atsiveria naujas langas)

Mo Y, Yam FK.

Šaltinis‎: Pharmacotherapy 2015;35(2):198-207.

Kodas‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (atsiveria naujas langas)

Idarucizumab for dabigatran reversal - full cohort analysis. (atsiveria naujas langas)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Šaltinis‎: N Engl J Med 2017;377(5):431-41.

Kodas‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (atsiveria naujas langas)

Oral anticoagulation in surgical procedures: risks and recommendations. (atsiveria naujas langas)

Torn M, Rosendaal FR.

Šaltinis‎: Br J Haematol 2003;123(4):676-82.

Kodas‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (atsiveria naujas langas)